These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2128025)

  • 1. The UK breast cancer screening programme: an expensive mistake.
    Rodgers A
    J Public Health Med; 1990; 12(3-4):197-204. PubMed ID: 2128025
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we undertake an MRI breast screening trial?
    Thorat MA
    Lancet; 2007 Dec; 370(9603):1902; author reply 1903-4. PubMed ID: 18068505
    [No Abstract]   [Full Text] [Related]  

  • 3. Biology and cost-benefit in mammography screening.
    Rutqvist LE
    Acta Oncol; 1997; 36(7):673-4. PubMed ID: 9490081
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mammography screening--advantages and disadvantages].
    Olsen AH; Schwartz W; Vejborg IM
    Ugeskr Laeger; 2007 Sep; 169(36):2977-9. PubMed ID: 17953873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving screening recall services for women with false-positive mammograms: a comparison of qualitative evidence with UK guidelines.
    Bond M; Garside R; Hyde C
    BMJ Open; 2015 Jan; 5(1):e005855. PubMed ID: 25618139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme.
    Beckett JR; Kotre CJ; Michaelson JS
    Br J Radiol; 2003 May; 76(905):309-20. PubMed ID: 12763946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dangers and unreliability of mammography: breast examination is a safe, effective, and practical alternative.
    Epstein SS; Bertell R; Seaman B
    Int J Health Serv; 2001; 31(3):605-15. PubMed ID: 11562008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [To the Editors: Comment on the study by Kullmann and Misset "Benefits of mammographic breast cancer screening"].
    Laszlo T
    Orv Hetil; 2010 Dec; 151(49):2032-3, discussion 2033-4.. PubMed ID: 21361059
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk benefit in mass screening programs for breast cancer.
    Miller AB
    Semin Oncol; 1978 Dec; 5(4):351-9. PubMed ID: 104389
    [No Abstract]   [Full Text] [Related]  

  • 10. British trial aims to settle mammography questions.
    Reynolds T
    J Natl Cancer Inst; 1995 Mar; 87(5):338-41. PubMed ID: 7853413
    [No Abstract]   [Full Text] [Related]  

  • 11. The UK breast screening program - what you need to know.
    Godley KC; Gladwell C; Murray PJ; Denton E
    Climacteric; 2017 Aug; 20(4):313-320. PubMed ID: 28661704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluating the benefits of mammographic breast cancer screening].
    Kullmann T; Misset JL
    Orv Hetil; 2010 Aug; 151(35):1409-14. PubMed ID: 20719714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
    Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
    Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical information for nurses. Mass screening for breast cancer].
    Kluck HM
    Tijdschr Ziekenverpl; 1987 Nov; 41(22):719-22. PubMed ID: 3424350
    [No Abstract]   [Full Text] [Related]  

  • 15. The UK breast-screening programme should start at age 47 years.
    Sasieni P; Cuzick J
    Lancet; 2003 Jul; 362(9379):246-7. PubMed ID: 12885493
    [No Abstract]   [Full Text] [Related]  

  • 16. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer?
    Mandelblatt JS; Stout N; Trentham-Dietz A
    Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer screening for women 40 to 49 years of age: what is a clinician to do?
    Gemignani ML
    Obstet Gynecol; 2007 Sep; 110(3):548-9. PubMed ID: 17766597
    [No Abstract]   [Full Text] [Related]  

  • 18. USPSTF erroneously understated life-years-gained benefit of mammographic screening of women in their 40s.
    Helvie MA; Petitti DB; Calonge N; Melnyk BM; Wilt TJ
    Radiology; 2011 Mar; 258(3):958-9. PubMed ID: 21339356
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invitation or summons? UK debate surrounds messages about mammography.
    Savage L
    J Natl Cancer Inst; 2009 Jul; 101(13):912-3. PubMed ID: 19549956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.